Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Graduate | 6 | 2024 | 411 | 1.110 |
Why?
|
| Internship and Residency | 10 | 2024 | 1083 | 0.990 |
Why?
|
| Internal Medicine | 8 | 2021 | 364 | 0.910 |
Why?
|
| Ventilator Weaning | 2 | 2013 | 25 | 0.800 |
Why?
|
| Educational Measurement | 3 | 2021 | 235 | 0.760 |
Why?
|
| Clinical Competence | 6 | 2024 | 807 | 0.690 |
Why?
|
| Muscle, Smooth | 9 | 2011 | 355 | 0.680 |
Why?
|
| Clinical Clerkship | 1 | 2021 | 120 | 0.630 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 183 | 0.580 |
Why?
|
| Gastroenterology | 4 | 2021 | 152 | 0.520 |
Why?
|
| Serum Response Factor | 4 | 2010 | 45 | 0.470 |
Why?
|
| Ultrasonography | 1 | 2016 | 707 | 0.430 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2013 | 22 | 0.410 |
Why?
|
| Azathioprine | 1 | 2013 | 124 | 0.400 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 145 | 0.390 |
Why?
|
| Cytomegalovirus Infections | 1 | 2013 | 153 | 0.380 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 78 | 0.360 |
Why?
|
| Students, Medical | 3 | 2021 | 433 | 0.350 |
Why?
|
| Asthma | 9 | 2017 | 1003 | 0.340 |
Why?
|
| Liver Diseases | 3 | 2021 | 246 | 0.310 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 989 | 0.290 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 775 | 0.250 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 35 | 0.220 |
Why?
|
| Curriculum | 4 | 2021 | 582 | 0.210 |
Why?
|
| Mentors | 1 | 2024 | 94 | 0.210 |
Why?
|
| Career Choice | 3 | 2021 | 153 | 0.210 |
Why?
|
| Humans | 29 | 2024 | 92303 | 0.200 |
Why?
|
| Hospitals, Teaching | 1 | 2001 | 118 | 0.180 |
Why?
|
| Documentation | 1 | 2001 | 103 | 0.180 |
Why?
|
| Licensure, Medical | 1 | 2021 | 22 | 0.180 |
Why?
|
| Medical Staff, Hospital | 1 | 2001 | 109 | 0.170 |
Why?
|
| Accreditation | 1 | 2021 | 62 | 0.170 |
Why?
|
| Trachea | 5 | 2011 | 291 | 0.170 |
Why?
|
| Teaching | 1 | 2001 | 146 | 0.170 |
Why?
|
| Geographic Mapping | 1 | 2019 | 12 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2010 | 612 | 0.150 |
Why?
|
| School Admission Criteria | 1 | 2019 | 28 | 0.150 |
Why?
|
| Peer Group | 1 | 2019 | 89 | 0.150 |
Why?
|
| Leadership | 1 | 2019 | 146 | 0.140 |
Why?
|
| Reference Standards | 1 | 2018 | 143 | 0.140 |
Why?
|
| Semaphorins | 1 | 2017 | 17 | 0.140 |
Why?
|
| United States | 6 | 2021 | 7346 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 5 | 0.130 |
Why?
|
| HLA-G Antigens | 2 | 2013 | 52 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 205 | 0.120 |
Why?
|
| Writing | 1 | 2015 | 29 | 0.120 |
Why?
|
| Male | 13 | 2021 | 43924 | 0.120 |
Why?
|
| Lung | 3 | 2017 | 1337 | 0.110 |
Why?
|
| Patient Handoff | 1 | 2015 | 95 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 130 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 461 | 0.100 |
Why?
|
| Actins | 4 | 2011 | 469 | 0.100 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2012 | 4 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2017 | 702 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 12 | 0.100 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2012 | 18 | 0.100 |
Why?
|
| Positive-Pressure Respiration | 1 | 2012 | 46 | 0.100 |
Why?
|
| Cough | 1 | 2012 | 56 | 0.100 |
Why?
|
| Dyspnea | 1 | 2012 | 80 | 0.100 |
Why?
|
| Eosinophilia | 1 | 2012 | 86 | 0.100 |
Why?
|
| Muscle Proteins | 3 | 2004 | 131 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 5430 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 176 | 0.090 |
Why?
|
| Microfilament Proteins | 3 | 2004 | 212 | 0.090 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Female | 11 | 2021 | 47894 | 0.090 |
Why?
|
| Dimerization | 1 | 2010 | 145 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 140 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 130 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 183 | 0.080 |
Why?
|
| Pneumonia | 1 | 2011 | 187 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 239 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 307 | 0.080 |
Why?
|
| Muscle Contraction | 3 | 2011 | 287 | 0.080 |
Why?
|
| Dogs | 6 | 2011 | 705 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 441 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 364 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2011 | 47 | 0.080 |
Why?
|
| Leukocytes | 1 | 2010 | 213 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 559 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2010 | 205 | 0.080 |
Why?
|
| Contractile Proteins | 2 | 2011 | 57 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2010 | 227 | 0.080 |
Why?
|
| Protein Binding | 2 | 2010 | 1514 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2011 | 283 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 141 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 575 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2016 | 4469 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 971 | 0.070 |
Why?
|
| Myosin Heavy Chains | 3 | 2004 | 91 | 0.070 |
Why?
|
| Smad7 Protein | 1 | 2006 | 7 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 2506 | 0.060 |
Why?
|
| Bronchi | 2 | 2004 | 232 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1073 | 0.060 |
Why?
|
| Aged | 4 | 2017 | 19952 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1960 | 0.060 |
Why?
|
| Respiratory System | 1 | 2004 | 119 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 328 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 1786 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 242 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 277 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2004 | 215 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 77 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 86 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 48 | 0.050 |
Why?
|
| Adult | 6 | 2021 | 27535 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 130 | 0.040 |
Why?
|
| Data Collection | 1 | 2001 | 379 | 0.040 |
Why?
|
| Animals | 10 | 2016 | 28044 | 0.040 |
Why?
|
| Mutation | 1 | 2010 | 4210 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 1248 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 1315 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2006 | 2907 | 0.040 |
Why?
|
| Education, Medical | 1 | 2001 | 246 | 0.040 |
Why?
|
| Hypertrophy | 2 | 2011 | 67 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 325 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1607 | 0.030 |
Why?
|
| China | 1 | 2018 | 248 | 0.030 |
Why?
|
| Genome, Human | 1 | 2002 | 802 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 19 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 657 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2016 | 109 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1095 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 735 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2015 | 9 | 0.030 |
Why?
|
| Insurance Benefits | 1 | 2015 | 8 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 22 | 0.030 |
Why?
|
| Allergens | 1 | 2016 | 189 | 0.030 |
Why?
|
| Middle Aged | 4 | 2017 | 27043 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 1164 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2015 | 197 | 0.030 |
Why?
|
| Feedback | 1 | 2015 | 137 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 159 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2011 | 1142 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 680 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2729 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 965 | 0.030 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 3 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 6628 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2013 | 60 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2012 | 127 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 88 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 1594 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 843 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 132 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 239 | 0.020 |
Why?
|
| Steroids | 1 | 2012 | 173 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1016 | 0.020 |
Why?
|
| American Heart Association | 1 | 2011 | 95 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 45 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1920 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 359 | 0.020 |
Why?
|
| Piperazines | 1 | 2012 | 288 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 72 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 651 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 378 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 698 | 0.020 |
Why?
|
| Solubility | 1 | 2010 | 185 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2011 | 507 | 0.020 |
Why?
|
| Inpatients | 1 | 2011 | 331 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 1865 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1239 | 0.020 |
Why?
|
| Phenotype | 2 | 2004 | 2502 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1902 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2011 | 3508 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2006 | 30 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 277 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 2007 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1724 | 0.010 |
Why?
|
| Respiratory Tract Diseases | 1 | 2004 | 45 | 0.010 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 48 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 901 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 36 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1131 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 13 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2003 | 18 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2003 | 18 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 67 | 0.010 |
Why?
|
| Amides | 1 | 2003 | 56 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 125 | 0.010 |
Why?
|
| Elasticity | 1 | 2003 | 101 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2004 | 210 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2002 | 12 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2003 | 97 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 128 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 115 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 382 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 162 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 2368 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 392 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 269 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 358 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5705 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 22 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6916 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 2000 | 14 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 311 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 390 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2000 | 70 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 214 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 202 | 0.010 |
Why?
|
| Serine | 1 | 2000 | 105 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 453 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 284 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 410 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 268 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 8727 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 644 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 524 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1938 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 741 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 876 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2319 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2037 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 9679 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3018 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1183 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 1689 | 0.010 |
Why?
|